Michael Grace

Michael Grace has over 30 years of experience in the pharmaceutical industry. Michael began their career in 1988 as a Senior Development Fellow at Schering-Plough. Michael then joined Bristol-Myers Squibb in 2005 as a Director and Executive Director. In 2012, they moved to NPS Pharmaceuticals as Senior Director. In 2016, they became Executive Director at Advaxis, Inc. and in 2017 they were promoted to Vice President at Advaxis Immunotherapies. Most recently, they founded and became the CEO of Bermuda Biotech, Inc. in 2019.

Michael Grace obtained a B.S. in Chemistry from the University of Nebraska-Lincoln between 1975 and 1979. Michael then continued their studies at the same institution, graduating with a Ph.D. in Biochemistry in 1984.